239 related articles for article (PubMed ID: 20431384)
21. [Vasculitides of pyococcal origin].
Shaposhnikov OK; Domaseva TV; Stogov IuN; Pokhodzeĭ IV; Karpenkova NI
Vestn Dermatol Venerol; 1983 Feb; (2):4-8. PubMed ID: 6845872
[No Abstract] [Full Text] [Related]
22. Vancomycin: specialized niche for a narrow-spectrum antibiotic.
Kasik JE
Iowa Med; 1988 Jun; 78(6):278-81. PubMed ID: 3290152
[No Abstract] [Full Text] [Related]
23. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
Shorin VA; Pevzner NS
Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
[No Abstract] [Full Text] [Related]
24. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
Deresinski S
Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.
Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP
Clin Infect Dis; 2009 Aug; 49(3):325-7. PubMed ID: 19569969
[TBL] [Abstract][Full Text] [Related]
26. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
Tsuchiya K; Kondo M; Oishi T; Yamazaki I
J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300
[No Abstract] [Full Text] [Related]
27. [Therapeutic progress: vancomycin].
Cuevas R; Sánchez J; Gorbea HF; Ramírez-Ronda CH
Bol Asoc Med P R; 1985 Jul; 77(7):269-70. PubMed ID: 3864446
[No Abstract] [Full Text] [Related]
28. [On contemporary rational penicillin treatment].
Welcker ER
Z Arztl Fortbild (Jena); 1965 Dec; 59(23):1250-3. PubMed ID: 5178687
[No Abstract] [Full Text] [Related]
29. Muscle abscesses in children.
Chacha PB
Clin Orthop Relat Res; 1970; 70():174-80. PubMed ID: 4986501
[No Abstract] [Full Text] [Related]
30. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies].
Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J
Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309
[No Abstract] [Full Text] [Related]
31. The usefulness of erythromycin in paediatrics.
Gołeebiowska H; Prokopczyk J; Pawluch D; Nowakowska K; Bozkowa K
J Chemother; 1989 Jul; 1(4 Suppl):689-90. PubMed ID: 16312594
[No Abstract] [Full Text] [Related]
32. [Pharmacokinetics of vancomycin in neonates of postconceptional age less than or equal to 32 weeks].
Ginovart Galiana G; Mangues Bafalluy MA; Demestre Guasch X; Farré Riba R; Lopes Santos AP; Altirriba Valls O
An Esp Pediatr; 1996 Aug; 45(2):167-71. PubMed ID: 8967647
[TBL] [Abstract][Full Text] [Related]
33. A patient with penicillin-resistant viridans group streptococcal endocarditis and unusual reactions to vancomycin.
Apiwattanakul N; Wanitkun S; Chongtrakool P; Sirinavin S
Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1088-91. PubMed ID: 19062700
[TBL] [Abstract][Full Text] [Related]
34. [Future of antibiotic therapy in various fields of medicine. 4. Pediatrics].
Kobayashi Y; Haruta T; Kuroki S
Nihon Rinsho; 1984 Mar; 42(3):598-604. PubMed ID: 6381800
[No Abstract] [Full Text] [Related]
35. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
[TBL] [Abstract][Full Text] [Related]
36. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies].
Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F
Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434
[No Abstract] [Full Text] [Related]
37. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
[TBL] [Abstract][Full Text] [Related]
38. Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates.
Leroux S; van den Anker JN; Smits A; Pfister M; Allegaert K
Br J Clin Pharmacol; 2019 May; 85(5):865-867. PubMed ID: 30834552
[No Abstract] [Full Text] [Related]
39. Outcomes associated with AUC24/MIC nomogram dosing of vancomycin.
Michalets EL; Pounders CL; Hollis SJ; Sutherland S
Ann Pharmacother; 2011 May; 45(5):687-9. PubMed ID: 21521857
[No Abstract] [Full Text] [Related]
40. [Antibiotics: the race continues].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2012 Sep; 35(9):311. PubMed ID: 23050347
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
